BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17227113)

  • 1. Differential expression of kinase genes in primary hyperparathyroidism: adenoma versus normal and hyperplastic parathyroid tissue.
    Schachter PP; Ayesh S; Matouk I; Schneider T; Czerniak A; Hochberg A
    Arch Pathol Lab Med; 2007 Jan; 131(1):126-30. PubMed ID: 17227113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of kinase genes in primary hyperparathyroidism: adenoma versus hyperplastic parathyroid tissue.
    Schachter PP; Ayesh S; Schneider T; Laster M; Czerniak A; Hochberg A
    Surgery; 2002 Dec; 132(6):1094-8; discussion 1098-9. PubMed ID: 12490860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma.
    Velázquez-Fernández D; Laurell C; Saqui-Salces M; Pantoja JP; Candanedo-Gonzalez F; Reza-Albarrán A; Gamboa-Dominguez A; Herrera MF
    World J Surg; 2006 May; 30(5):705-13. PubMed ID: 16680586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.
    Sadowski SM; Pusztaszeri M; Brulhart-Meynet MC; Petrenko V; De Vito C; Sobel J; Delucinge-Vivier C; Kebebew E; Regazzi R; Philippe J; Triponez F; Dibner C
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2189-2198. PubMed ID: 29659895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The profile of ErbB/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism.
    Bednarz N; Błaut K; Sworczak K; Oseka T; Bielawski KP
    Acta Biochim Pol; 2009; 56(1):83-8. PubMed ID: 19259547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
    Buchwald PC; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of parathyroid neoplasia by gene expression profiling.
    Morrison C; Farrar W; Kneile J; Williams N; Liu-Stratton Y; Bakaletz A; Aldred MA; Eng C
    Am J Pathol; 2004 Aug; 165(2):565-76. PubMed ID: 15277230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
    Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
    Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions.
    Lazaris AC; Tseleni-Balafouta S; Papathomas T; Brousalis T; Thomopoulou G; Agrogiannis G; Patsouris ES
    Eur J Endocrinol; 2006 Jun; 154(6):827-33. PubMed ID: 16728542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of differentially expressed lncRNA in sporadic parathyroid tumors.
    Jiang T; Wei BJ; Zhang DX; Li L; Qiao GL; Yao XA; Chen ZW; Liu X; Du XY
    Osteoporos Int; 2019 Jul; 30(7):1511-1519. PubMed ID: 30972448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed microRNA in parathyroid tumors.
    Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
    Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in gene expression in the course of proliferative processes in the parathyroid gland].
    Szende B; Arvai K; Peták I; Nagy K; Végsô G; Perner F
    Magy Onkol; 2006; 50(2):137-40. PubMed ID: 16888677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology.
    Forsberg L; Björck E; Hashemi J; Zedenius J; Höög A; Farnebo LO; Reimers M; Larsson C
    Eur J Endocrinol; 2005 Mar; 152(3):459-70. PubMed ID: 15757864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
    Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
    Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism.
    Kebebew E; Peng M; Wong MG; Ginzinger D; Duh QY; Clark OH
    Surgery; 2004 Dec; 136(6):1261-6. PubMed ID: 15657585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics Analysis of Tissue Samples Reveals Changes in Mitochondrial Protein Levels in Parathyroid Hyperplasia over Adenoma.
    Akpinar G; Kasap M; Canturk NZ; Zulfigarova M; Islek EE; Guler SA; Simsek T; Canturk Z
    Cancer Genomics Proteomics; 2017; 14(3):197-211. PubMed ID: 28446534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma.
    Árvai K; Nagy K; Barti-Juhász H; Peták I; Krenács T; Micsik T; Végső G; Perner F; Szende B
    Pathol Oncol Res; 2012 Jul; 18(3):607-14. PubMed ID: 22198862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors.
    Arya AK; Singh P; Saikia UN; Sachdeva N; Dahiya D; Behera A; Rao SD; Bhadada SK
    J Endocrinol Invest; 2020 Feb; 43(2):247-253. PubMed ID: 31535356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.